M.R.R. v. HHS - HPV, Immune Thrombocytopenic Purpura (ITP) (2016)

On August 5, 2014, Amy L. Rawson, as mother and guardian of her minor child M.R.R., filed a petition under the National Vaccine Injury Compensation Program.

The petition alleged that M.R.R. suffered from Immune Thrombocytopenic Purpura (ITP) as a result of Human Papillomavirus (HPV) and Hepatitis A vaccinations administered on August 15, 2011, and July 26, 2012. The petitioner's name was later amended to Amy L.

Schipporiet. An amended petition also included allegations regarding a Tdap and MCV4 vaccine administered on July 26, 2012.

The parties later stipulated that the Tdap vaccine did not play a role in causing or aggravating the injury. The respondent denied that the HPV, Hepatitis A, or Tdap vaccines caused or significantly aggravated M.R.R.'s condition.

On January 26, 2016, the parties filed a joint stipulation agreeing to an award of compensation. Special Master Lisa Hamilton-Fieldman approved the stipulation.

M.R.R. was awarded a lump sum of $110,000.00, payable to Petitioner as guardian/conservator of M.R.R.'s estate, representing compensation for all damages. Petitioner was represented by Carol L.

Gallagher of Carol L. Gallagher, Esquire, LLC.

Respondent was represented by Debra A. Begley of the United States Department of Justice.

The decision was issued on February 22, 2016.